Myeloproliferative Neoplasms
Best Practices in Hematologic Malignancies – December 2017 Vol 8 | December 15, 2017
A recent survey of patients with myeloproliferative neoplasms (MPNs), including myelofibrosis, polycythemia vera, and essential thrombocythemia, has identified a strong association between symptom burden and medical disability leave.
Supplement October 2014 Vol 5, No 5 | April 10, 2016
A multidisciplinary roundtable was convened on May 29, 2014, to gain insight and guidance from experts on the diagnosis and management of polycythemia vera (PV), including practical strategies, recent advances, and the emerging science.
Supplement October 2014 Vol 5, No 5 | April 10, 2015
In an effort to crystallize the evolving and practical application of diagnostic algorithms, prognostication, therapeutic goal setting, and disease management, a multidisciplinary roundtable was convened, which was comprised of physicians from MPN-focused academic centers, community hematologists, outpatient nursing staff, insurance plan administrators, and specialty pharmacists.
Results 1 - 3 of 3